{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:30:20Z","timestamp":1738387820347,"version":"3.35.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.pbb.2008.08.025","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T17:20:00Z","timestamp":1221067200000},"page":"248-257","source":"Crossref","is-referenced-by-count":24,"title":["Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment"],"prefix":"10.1016","volume":"93","author":[{"given":"Nurith","family":"Amitai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2008.08.025_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0269881107067097","article-title":"Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat","volume":"21","author":"Abdul-Monim","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881103017001700","article-title":"The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat","volume":"17","author":"Abdul-Monim","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2006.01.019","article-title":"The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm","volume":"169","author":"Abdul-Monim","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1472-8206.2006.00411.x","article-title":"Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice","volume":"20","author":"Akhtar","year":"2006","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.135.9.1081","article-title":"Phencyclidine-induced psychosis","volume":"135","author":"Allen","year":"1978","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-007-0808-x","article-title":"Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats","volume":"193","author":"Amitai","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpsyc.1992.01820120031006","article-title":"Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London","volume":"49","author":"Andreasen","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S0033291701005128","article-title":"Acts of control in schizophrenia: dissociating the components of inhibition","volume":"32","author":"Badcock","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.pbb.2008.08.025_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-440X(61)80033-3","article-title":"Observations on the psychotomimetic effects of Sernyl","volume":"2","author":"Bakker","year":"1961","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0091-3057(79)90252-1","article-title":"Effects of phencyclidine, d-amphetamine and pentobarbital on spaced responding in mice","volume":"11","author":"Balster","year":"1979","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.08.025_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/cap.2006.16.665","article-title":"The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s)","volume":"16","author":"Barzman","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1461145705005924","article-title":"Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine","volume":"9","author":"Bender","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1176\/appi.ajp.159.6.1018","article-title":"Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder","volume":"159","author":"Bilder","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib14","first-page":"262","article-title":"Methylphenidate and neuroleptic effects on oral word production in schizophrenia","volume":"5","author":"Bilder","year":"1992","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"4409","key":"10.1016\/j.pbb.2008.08.025_bib15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.112679","article-title":"Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey","volume":"205","author":"Brozoski","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.pbb.2008.08.025_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0166-4328(83)90138-9","article-title":"Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal","volume":"9","author":"Carli","year":"1983","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/15563658209025737","article-title":"Phencyclidine intoxication: assessment of possible antidotes","volume":"19","author":"Castellani","year":"1982","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.pbb.2008.08.025_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-003-1710-9","article-title":"Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia","volume":"174","author":"Castner","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2005.08.011","article-title":"The components of executive functioning in a cohort of patients with chronic schizophrenia: a multiple single-case study design","volume":"81","author":"Chan","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0028-3908(00)00126-X","article-title":"Combinations of clozapine and phencyclidine: effects on drug discrimination and behavioral inhibition in rats","volume":"40","author":"Compton","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib22","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjp.0707160","article-title":"F15063, a compound with D2\/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: (III) Activity in models of cognition and negative symptoms","volume":"151","author":"Depoort\u00e8re","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00213-007-0774-3","article-title":"Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics","volume":"193","author":"Didriksen","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib25","first-page":"347","article-title":"Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study","volume":"25","author":"Dursun","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pbb.2008.08.025_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0920-9964(01)00323-1","article-title":"An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia","volume":"57","author":"East","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/PL00005481","article-title":"Varietis of impulsivity","volume":"146","author":"Evenden","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-007-0891-z","article-title":"Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test","volume":"195","author":"Fletcher","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.npp.1300332","article-title":"The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats","volume":"29","author":"Foley","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00207458808985758","article-title":"Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function","volume":"42","author":"Goldberg","year":"1988","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pbb.2008.08.025_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-004-1793-y","article-title":"Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction","volume":"174","author":"Goldman-Rakic","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-2999(87)90635-2","article-title":"Selective memory impairment by phencyclidine in rats","volume":"140","author":"Handelmann","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s002130050410","article-title":"Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms","volume":"133","author":"Harrison","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-005-2261-z","article-title":"5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats","volume":"181","author":"Hatcher","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbr.2005.11.014","article-title":"The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL\/Bax ratio in the posterior cingulate cortex in rats","volume":"168","author":"He","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00213-003-1549-0","article-title":"The 5-HT2A receptor antagonist M100,907 attenuates motor and impulsive-type behaviours produced by NMDA receptor antagonism","volume":"170","author":"Higgins","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/15622970309167910","article-title":"Quetiapine in the treatment of borderline personality disorder","volume":"4","author":"Hilger","year":"2003","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1124\/mol.64.6.1295","article-title":"Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling","volume":"64","author":"Hirst","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2006.09.049","article-title":"SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models","volume":"553","author":"Hirst","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib41","first-page":"71","article-title":"Serotonin-6 (5-HT6) receptor variant association study with clozapine response [Abstract]","volume":"49","author":"Huezo-Diaz","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib42","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2008.08.025_bib43","first-page":"056P","article-title":"Lamotrigine and clozapine reverse an established cognitive deficit induced by sub-chronic PCP (phencyclidine) in the rat","volume":"1","author":"Idris","year":"2003","journal-title":"Br J Pharmacol Proc Suppl"},{"key":"10.1016\/j.pbb.2008.08.025_bib44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00213-004-2058-5","article-title":"Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat","volume":"179","author":"Idris","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib45","first-page":"12","article-title":"Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia","volume":"9","author":"Javitt","year":"1987","journal-title":"Hillside J Clin Psychiatr"},{"key":"10.1016\/j.pbb.2008.08.025_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00213-004-1772-3","article-title":"A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats","volume":"175","author":"Jentsch","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0893-133X(00)00174-3","article-title":"Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats","volume":"24","author":"Jentsch","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0893-133X(97)00034-1","article-title":"Subchronic phencyclidine adminstration reduces mesoprefrontal dopamine utilization and impairs cortical-dependent cognition in the rat","volume":"17","author":"Jentsch","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/appi.ajp.161.6.985","article-title":"Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol","volume":"161","author":"Keefe","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-3223(00)00834-9","article-title":"An event-related potential investigation of response inhibition in schizophrenia and psychopathy","volume":"48","author":"Kiehl","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2004.03.012","article-title":"5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation\u2014an effect sensitive to NMDA receptor antagonism","volume":"47","author":"King","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pnpbp.2004.11.005","article-title":"Effects of quetiapine on cognitive functions in schizophrenia","volume":"29","author":"Kivircik Akdede","year":"2005","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2005.09.009","article-title":"Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes","volume":"81","author":"Kopala","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0959-4388(00)00068-4","article-title":"Schizophrenia and cognitive function","volume":"10","author":"Kuperberg","year":"2000","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pbb.2008.08.025_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000081242","article-title":"List of drugs in development for neurodegenerative diseases","volume":"1","author":"Kwon","year":"2004","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.pbb.2008.08.025_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-1781(99)00109-2","article-title":"Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives","volume":"89","author":"Laurent","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0091-3057(03)00082-0","article-title":"Effect of the 5-HT6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine","volume":"75","author":"Leng","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.08.025_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(02)02620-3","article-title":"5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner","volume":"947","author":"Li\u00e9geois","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib62","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.103.056002","article-title":"An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning","volume":"307","author":"Lindner","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.08.025_bib63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug: sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib64","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00213-001-0977-y","article-title":"\u201cTypical\u201d but not \u201catypical\u201d antipsychotic effects on startle gating deficits in prepubertal rats","volume":"161","author":"Martinez","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 11","key":"10.1016\/j.pbb.2008.08.025_bib65","first-page":"3","article-title":"The expert consensus guideline series: treatment of schizophrenia 1999","volume":"60","author":"McEvoy","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0920-9964(99)00198-X","article-title":"The role of cognition in vocational functioning in schizophrenia","volume":"45","author":"McGurk","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pbb.2008.08.025_bib68","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1358\/dnp.2001.14.7.660941","article-title":"Role of 5-HT6 receptors in memory formation","volume":"14","author":"Meneses","year":"2001","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pbb.2008.08.025_bib70","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.1990.tb01230.x","article-title":"Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study","volume":"54","author":"Moghaddam","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2008.08.025_bib71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1192\/bjp.157.1.50","article-title":"Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania","volume":"157","author":"Morice","year":"1990","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib72","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0091-3057(96)00425-X","article-title":"Cognitive function in schizophrenia: do neuroleptics make a difference?","volume":"56","author":"Mortimer","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.08.025_bib73","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S0033291700017670","article-title":"Cognitive functioning and symptomatology in chronic schizophrenia","volume":"20","author":"Nelson","year":"1990","journal-title":"Psychol Med"},{"key":"10.1016\/j.pbb.2008.08.025_bib74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/schbul\/10.2.160","article-title":"Information processing and attentional functioning in the developmental course of schizophrenic disorders","volume":"10","author":"Nuechterlein","year":"1984","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pbb.2008.08.025_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(01)02075-4","article-title":"Novel polymorphism in the 5'-upstream region of the human 5-HT6 receptor gene and schizophrenia","volume":"310","author":"Ohmori","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2008.08.025_bib76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.eurpsy.2007.02.005","article-title":"Antipsychotic efficacy: relationship to optimal D2-receptor occupancy","volume":"22","author":"Pani","year":"2007","journal-title":"Eur Psychiatr"},{"key":"10.1016\/j.pbb.2008.08.025_bib77","first-page":"25","article-title":"Psychiatric and medical syndromes associated with phencyclidine (PCP) abuse","volume":"148","author":"Pearlson","year":"1981","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.pbb.2008.08.025_bib78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0091-3057(01)00743-2","article-title":"Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia","volume":"71","author":"Pouzet","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.08.025_bib79","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0091-3057(01)00744-4","article-title":"Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia","volume":"71","author":"Pouzet","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2008.08.025_bib80","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0149-7634(84)90006-X","article-title":"Phencyclidine (PCP): some human studies","volume":"8","author":"Pradhan","year":"1984","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2008.08.025_bib81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0306-4522(97)00392-8","article-title":"Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task","volume":"83","author":"Puumala","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2008.08.025_bib82","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/nlme.1996.0060","article-title":"Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder","volume":"66","author":"Puumala","year":"1996","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pbb.2008.08.025_bib83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1993.01820140007001","article-title":"The de facto US mental and addictive disorders service system: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services","volume":"50","author":"Regier","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib84","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","article-title":"The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry","volume":"163","author":"Robbins","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib85","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1460-9568.2005.03937.x","article-title":"PDE10A inhibition reverses subchronic PCP-induced decifits in attentional set-shifting in rats","volume":"21","author":"Rodefer","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2008.08.025_bib86","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/sj.npp.1301654","article-title":"Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT(6) receptor antagonist: comparison among antipsychotics","volume":"33","author":"Rodefer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib87","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002130100840","article-title":"5-HT6 receptor antagonists enhance retention of a water maze task in the rat","volume":"158","author":"Rogers","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib88","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archpsyc.1959.03590060113013","article-title":"Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. attention, motor function, and proprioception","volume":"1","author":"Rosenbaum","year":"1959","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199601000-00001","article-title":"Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia","volume":"7","author":"Sams-Dodd","year":"1996","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib90","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0022-3565(25)24143-X","article-title":"Effects of phencyclidine and other N-methyl-d-aspartate antagonists on the schedule-controlled behavior of rats","volume":"248","author":"Sanger","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.08.025_bib91","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1126\/science.1825731","article-title":"D1 dopamine receptors in prefrontal cortex: involvement in working memory","volume":"251","author":"Sawaguchi","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.pbb.2008.08.025_bib92","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib93","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib94","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.156.6.876","article-title":"Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine","volume":"156","author":"Seeman","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopsych.2006.12.011","article-title":"Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition","volume":"63","author":"Semenova","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0193-953X(02)00084-9","article-title":"Cognitive function in schizophrenia: deficits, functional consequences, and future treatment","volume":"26","author":"Sharma","year":"2003","journal-title":"Psychiatr Clin North Am"},{"issue":"2 Suppl 1","key":"10.1016\/j.pbb.2008.08.025_bib97","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/00004714-199804001-00004","article-title":"The cognitive efficacy of atypical antipsychotics in schizophrenia","volume":"18","author":"Sharma","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib98","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/(SICI)1096-8628(19990416)88:2<120::AID-AJMG4>3.0.CO;2-Y","article-title":"Association study of the 5-HT6 receptor gene in schizophrenia","volume":"88","author":"Shinkai","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pbb.2008.08.025_bib99","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00002826-199710000-00009","article-title":"Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients","volume":"20","author":"Spivak","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0735-7044.119.2.420","article-title":"Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats","volume":"119","author":"Stefani","year":"2005","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pbb.2008.08.025_bib101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0166-4328(95)00162-X","article-title":"The behavioral and neurochemical effects of phenyclidine in humans and animals: some implications for modeling psychosis","volume":"74","author":"Steinpreis","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib102","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/hup.764","article-title":"Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study","volume":"21","author":"Strous","year":"2006","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib103","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0022-3565(25)21289-7","article-title":"Seroquel restores sensorimotor gating in phencyclidine-treated rats","volume":"279","author":"Swerdlow","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2008.08.025_bib104","first-page":"20","article-title":"Procognitive effects of the 5-HT6 receptor antagonist Ro 4368554 in rats","volume":"290","author":"Szczepanski","year":"2002","journal-title":"Soc Neurosci Meet"},{"key":"10.1016\/j.pbb.2008.08.025_bib105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0269881105056639","article-title":"A comparison of multiple 5-HT receptors in two tasks measuring impulsivity","volume":"20","author":"Talpos","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2008.08.025_bib106","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S0033291700032773","article-title":"Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character","volume":"22","author":"Tamlyn","year":"1992","journal-title":"Psychol Med"},{"key":"10.1016\/j.pbb.2008.08.025_bib107","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(99)00542-X","article-title":"Association study of serotonin-6 receptor variant (C267\u00a0T) with schizophrenia and aggressive behavior","volume":"271","author":"Tsai","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2008.08.025_bib108","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0920-9964(01)00268-7","article-title":"Does cognitive function improve with quetiapine in comparison to haloperidol?","volume":"53","author":"Velligan","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib109","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.4088\/JCP.v66n1013","article-title":"Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target","volume":"66","author":"Villeneuve","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1471-4159.1997.69010182.x","article-title":"BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex","volume":"69","author":"Volont\u00e9","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2008.08.025_bib111","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/0306624X03253027","article-title":"Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine","volume":"47","author":"Walker","year":"2003","journal-title":"Int J Offender Ther Comp Criminol"},{"key":"10.1016\/j.pbb.2008.08.025_bib112","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archpsyc.1986.01800020020004","article-title":"Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence","volume":"43","author":"Weinberger","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib113","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archpsyc.1988.01800310013001","article-title":"Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism","volume":"45","author":"Weinberger","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib114","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0006-3223(99)00218-8","article-title":"Executive control is disturbed in schizophrenia: evidence from event-related potentials in a Go\/NoGo task","volume":"47","author":"Weisbrod","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00213-003-1398-x","article-title":"Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats","volume":"167","author":"Winstanley","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2008.08.025_bib116","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00056-9","article-title":"A role for 5-HT6 receptors in retention of spatial learning in the Morris water maze","volume":"41","author":"Woolley","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib117","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00213-003-1552-5","article-title":"Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790","volume":"170","author":"Woolley","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2008.08.025_bib118","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-HT6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pbb.2008.08.025_bib119","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0920-9964(99)00233-9","article-title":"The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia","volume":"46","author":"Wykes","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2008.08.025_bib120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/ajp.136.2.235-a","article-title":"Letter","volume":"136","author":"Yesavage","year":"1979","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2008.08.025_bib121","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00001756-199904260-00014","article-title":"Serotonin-6 receptor variant (C267T) and clinical response to clozapine","volume":"10","author":"Yu","year":"1999","journal-title":"NeuroReport"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305708003134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305708003134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:03:19Z","timestamp":1738360999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305708003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0091305708003134"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2008.08.025","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}